Physician

Psychiatry

Dr. Shamsah B. Sonawalla, MD

Shamsah Sonawalla is an expert in the field of Psychiatry. Doctor Shamsah B. Sonawalla, MD has written publications. She has 26 publications published with PubMed. The lastest publication is: 'Placebo response in depression.'

Publications

A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.
Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
Citalopram in the maintenance treatment of major depressive disorder.
Severe depression: is there a best approach?
Coping mechanisms in patients presenting for in-vitro-fertilization.
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory.
Personality disorders and depression.
Early improvements in anxiety, depression, and anger/hostility symptoms and response to antidepressant treatment.
A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression.
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Prevalence of major depressive disorder among Chinese-Americans in primary care.
Treatment of major depression and anxiety with the selective serotonin re-uptake enhancer tianeptine in the outpatient psychiatric care setting of India.
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Serum cholesterol in treatment-resistant depression.
Somatic symptoms in treatment-resistant depression.
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis.
Placebo response in depression.

Doctors Specialties

Psychiatry

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Lisa M. Zakhary, MD This Doctor is OpenDoctor Recommended.
	Dr. Shane M. Coleman, MD This Doctor is OpenDoctor Recommended.
	Dr. Bibi H. Alamiri, MD This Doctor is OpenDoctor Recommended.
	Dr. Erwin M. Ilano, MD This Doctor is OpenDoctor Recommended.
	Dr. David J. Wolfe, MD This Doctor is OpenDoctor Recommended.
	Dr. John J. Worthington III, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Philip S. Wang, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ingrid H. Wright, MD
	Dr. Catherine Gonzalez, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph J. Jankowski, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert D. Mendenhall, MD
	Dr. Samara Ahmed, MD This Doctor is OpenDoctor Recommended.
	Dr. Sean A. Minjares, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael Colon, MD